Metabolix, Inc. (NASDAQ:YTEN) released its earnings results on Thursday. The specialty chemicals company reported ($0.96) EPS for the quarter, Bloomberg Earnings reports. The business had revenue of $0.29 million for the quarter. Metabolix had a negative net margin of 190.57% and a negative return on equity of 121.28%.
Metabolix (NASDAQ:YTEN) opened at 2.2462 on Friday. Metabolix has a 1-year low of $0.25 and a 1-year high of $9.03. The stock’s 50 day moving average price is $3.35 and its 200-day moving average price is $1.77. The company’s market cap is $6.40 million.
ILLEGAL ACTIVITY WARNING: This piece of content was originally posted by Community Financial News and is owned by of Community Financial News. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece of content can be viewed at https://www.com-unik.info/2017/08/12/metabolix-inc-yten-releases-earnings-results.html.
Yield10 Bioscience, Inc, formerly Metabolix, Inc, is an agricultural bioscience company. The Company is focused on developing disruptive technologies for step-change improvements in crop yield for food and feed crops to enhance global food security. By working on new approaches to improve fundamental elements of plant photosynthetic efficiency and optimizing carbon metabolism to direct more carbon to seed production, the Company is advancing several yield traits it has developed in crops, such as Camelina, canola, soybean and corn.
What are top analysts saying about Metabolix Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Metabolix Inc. and related companies.